MannKind reported $14.38M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Adma Biologics USD 35.66M 3.94M Sep/2026
BioCryst Pharmaceuticals USD 14.58M 3.12M Sep/2026
Eli Lilly USD 5.79B 319M Sep/2026
Halozyme Therapeutics USD 33.55M 9.94M Sep/2026
Insmed USD 84.3M 9.75M Sep/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
MacroGenics USD 3.14M 300K Sep/2026
MannKind USD 14.38M 3.34M Sep/2026
Merck USD 5.03B 1.2B Sep/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Novavax USD 24.94M 2.01M Sep/2026
Novo Nordisk DKK 2.23B 131.82B Jun/2026
Pfizer USD 4.07B 511M Sep/2026
Sanofi EUR 24.55B 957M Sep/2026
Xencor USD 6.65M 6M Sep/2026